Similar articles for PMID: 31405148

Year	Number of Results
2012	1
2013	1
2014	3
2015	4
2016	8
2017	7
2018	19
2019	21
2020	9
2022	2
2023	3
2024	0

1

Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type Glioblastoma.

Chaddad A, Daniel P, Sabri S, Desrosiers C, Abdulkarim B. Chaddad A, et al. Cancers (Basel). 2019 Aug 10;11(8):1148. doi: 10.3390/cancers11081148. Cancers (Basel). 2019. PMID: 31405148 Free PMC article.

2

Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme.

Bernal Rubio YL, González-Reymúndez A, Wu KH, Griguer CE, Steibel JP, de Los Campos G, Doseff A, Gallo K, Vazquez AI. Bernal Rubio YL, et al. G3 (Bethesda). 2018 Nov 6;8(11):3627-3636. doi: 10.1534/g3.118.200391. G3 (Bethesda). 2018. PMID: 30228192 Free PMC article.

3

Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.

Lee MH, Kim J, Kim ST, Shin HM, You HJ, Choi JW, Seol HJ, Nam DH, Lee JI, Kong DS. Lee MH, et al. World Neurosurg. 2019 May;125:e688-e696. doi: 10.1016/j.wneu.2019.01.157. Epub 2019 Feb 5. World Neurosurg. 2019. PMID: 30735871

4

Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.

Choi Y, Ahn KJ, Nam Y, Jang J, Shin NY, Choi HS, Jung SL, Kim BS. Choi Y, et al. Eur J Radiol. 2019 Nov;120:108642. doi: 10.1016/j.ejrad.2019.108642. Epub 2019 Sep 14. Eur J Radiol. 2019. PMID: 31546124

5

Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.

Prasanna P, Patel J, Partovi S, Madabhushi A, Tiwari P. Prasanna P, et al. Eur Radiol. 2017 Oct;27(10):4188-4197. doi: 10.1007/s00330-016-4637-3. Epub 2016 Oct 24. Eur Radiol. 2017. PMID: 27778090 Free PMC article.

6

Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.

Chen X, Fang M, Dong D, Liu L, Xu X, Wei X, Jiang X, Qin L, Liu Z. Chen X, et al. Acad Radiol. 2019 Oct;26(10):1292-1300. doi: 10.1016/j.acra.2018.12.016. Epub 2019 Jan 17. Acad Radiol. 2019. PMID: 30660472

7

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.

Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, Verlingue L, Brandao D, Lancia A, Ammari S, Hollebecque A, Scoazec JY, Marabelle A, Massard C, Soria JC, Robert C, Paragios N, Deutsch E, Ferté C. Sun R, et al. Lancet Oncol. 2018 Sep;19(9):1180-1191. doi: 10.1016/S1470-2045(18)30413-3. Epub 2018 Aug 14. Lancet Oncol. 2018. PMID: 30120041

8

Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.

Kickingereder P, Neuberger U, Bonekamp D, Piechotta PL, Götz M, Wick A, Sill M, Kratz A, Shinohara RT, Jones DTW, Radbruch A, Muschelli J, Unterberg A, Debus J, Schlemmer HP, Herold-Mende C, Pfister S, von Deimling A, Wick W, Capper D, Maier-Hein KH, Bendszus M. Kickingereder P, et al. Neuro Oncol. 2018 May 18;20(6):848-857. doi: 10.1093/neuonc/nox188. Neuro Oncol. 2018. PMID: 29036412 Free PMC article.

9

Apparent Diffusion Coefficient as a Predictive Biomarker for Survival in Patients with Treatment-Naive Glioblastoma Using Quantitative Multiparametric Magnetic Resonance Profiling.

Kim BS, Kim ST, Kim JH, Seol HJ, Nam DH, Shin HJ, Lee JI, Kong DS. Kim BS, et al. World Neurosurg. 2019 Feb;122:e812-e820. doi: 10.1016/j.wneu.2018.10.151. Epub 2018 Nov 1. World Neurosurg. 2019. PMID: 30391622

10

A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.

Zinn PO, Singh SK, Kotrotsou A, Hassan I, Thomas G, Luedi MM, Elakkad A, Elshafeey N, Idris T, Mosley J, Gumin J, Fuller GN, de Groot JF, Baladandayuthapani V, Sulman EP, Kumar AJ, Sawaya R, Lang FF, Piwnica-Worms D, Colen RR. Zinn PO, et al. Clin Cancer Res. 2018 Dec 15;24(24):6288-6299. doi: 10.1158/1078-0432.CCR-17-3420. Epub 2018 Jul 27. Clin Cancer Res. 2018. PMID: 30054278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year